Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2011
10/27/2011US20110263644 Compounds and Methods for Treatment of Stroke
10/27/2011US20110263643 2,3-Disubstituted Piperidine Orexin Receptor Antagonists
10/27/2011US20110263642 Methods for treatment of multiple sclerosis
10/27/2011US20110263641 Isoxazolines For Controlling Invertebrate Pests
10/27/2011US20110263640 8-azabicyclo[3.2.1]oct-2-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/27/2011US20110263639 Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase
10/27/2011US20110263638 Therapeutic agent for glaucoma comprising rho kinase inhibitor and ß- blocker
10/27/2011US20110263637 Up to six weeks dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75% imiquimod
10/27/2011US20110263636 3 x 3 x 3 WEEK DOSING REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 3.75 % IMIQUIMOD
10/27/2011US20110263635 Method of treating actinic keratosis with 3.75% imiquimod cream
10/27/2011US20110263634 Lower dosage strength pharmaceutical compositions formulated with 2.5% imiquimod
10/27/2011US20110263633 Up to six weeks treatment regimen for treating actinic keratoses with pharmaceutical compositions formulated with 2.5% imiquimod
10/27/2011US20110263632 Solid dispersions comprising tacrolimus
10/27/2011US20110263631 Combination of a serotonin and norepinephrine reuptake inhibitor and an opioid agonist for the treatment of pain
10/27/2011US20110263630 Synthesis of metabolically stable agents for alcohol and drug abuse
10/27/2011US20110263629 Amides of diazabicyclooctanes and uses thereof
10/27/2011US20110263628 N-hydroxyamide derivatives and use thereof
10/27/2011US20110263626 Novel bradykinin b1-antagonists
10/27/2011US20110263625 Hiv replication inhibiting pyrimidines
10/27/2011US20110263624 Bicyclic heterocycle derivatives and methods of use thereof
10/27/2011US20110263623 Process for preparation of bosentan
10/27/2011US20110263622 Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors
10/27/2011US20110263621 NEW COMBINATION OF ACTIVE INGREDIENTS CONTAINING AN a1-ANTAGONIST AND A PDE 4 INHIBITOR
10/27/2011US20110263620 Quinoline compounds and their use for treating viral infection
10/27/2011US20110263619 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure
10/27/2011US20110263617 Combination therapy for the treatment of diabetes and related conditions
10/27/2011US20110263616 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene maleate salt
10/27/2011US20110263615 Pyridine and pyrimidine derivatives as mglur2 antagonists
10/27/2011US20110263614 Novel compounds
10/27/2011US20110263613 Compounds and compositions for cognition-enhancement, methods of making, and methods of treating
10/27/2011US20110263612 Compounds that modulate intracellular calcium
10/27/2011US20110263611 Kinase Inhibitors
10/27/2011US20110263610 Compounds and compositions as itpkb inhibitors
10/27/2011US20110263609 Methods of Identifying and Treating Individuals Exhibiting NUP214-ABL1 Positive T-Cell Malignancies with Protein Tyrosine Kinase Inhibitors and Combinations Thereof
10/27/2011US20110263608 16-keto aspergillimides and harmful organism control agent comprising the same as active ingredient
10/27/2011US20110263607 Alpha helix mimetics in the treatment of cancer
10/27/2011US20110263606 Solid oral dosage forms comprising tadalafil
10/27/2011US20110263605 Azabicyclo[2.2.1]Heptane Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands
10/27/2011US20110263604 Oxidase inhibitors and their use
10/27/2011US20110263603 Imine Compounds for Combating Invertebrate Pests
10/27/2011US20110263602 Tetrasubstituted pyridazine hedgehog pathway antagonists
10/27/2011US20110263601 Methods of treating ulcerative colitis
10/27/2011US20110263600 Method for preventing or treating a disease related to the glucocorticoid receptor
10/27/2011US20110263599 7-nonsubstituted indole mcl-1 inhibitors
10/27/2011US20110263598 Kinase inhibitors and method of treating cancer
10/27/2011US20110263597 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
10/27/2011US20110263596 2-oxo-3-benzylbenzoxazol-2-one derivatives and related compounds as met kinase inhibitors for the treatment of tumours
10/27/2011US20110263595 Compounds and methods for kinase modulation, and indications therefor
10/27/2011US20110263594 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors
10/27/2011US20110263593 NOVEL IMIDAZO[1,2-a]PYRIMIDINE DERIVATIVES, METHOD FOR THE PREPARATION THEREOF, USE THEREOF AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE, IN PARTICULAR AS MET INHIBITORS
10/27/2011US20110263592 Imidazo[1,2-a]pyridine derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
10/27/2011US20110263591 2-heteroaryl carboxamides
10/27/2011US20110263590 Antibacterial Compositions
10/27/2011US20110263589 Method for preventing or treating a glucocorticoid receptor-related disease
10/27/2011US20110263588 Tricyclic compounds as glutamate receptor modulators
10/27/2011US20110263587 Reversibly heat-gelable aqueous composition
10/27/2011US20110263584 Cyclic Inhibitors Of 11Beta-Hydroxysteroid Dehydrogenase 1
10/27/2011US20110263583 Cyclic Inhibitors Of 11Beta-Hydroxysteroid Dehydrogenase 1
10/27/2011US20110263582 Cyclic urea inhibitors of 11 b-hydroxysteroid dehydrogenase 1
10/27/2011US20110263581 Fused tricyclic compounds as serine-threonine protein kinase and parp modulators
10/27/2011US20110263580 Method for treating alzheimer's disease and related conditions
10/27/2011US20110263579 Chlorothiazide, chlorothiazide salts and pharmaceutical compositions thereof
10/27/2011US20110263578 Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes
10/27/2011US20110263577 Novel oxadiazolyl-diazabicyclononane derivatives and their medical use
10/27/2011US20110263576 Pharmaceutical composition containing benzodiazepine and/or benzodiazepine derivatives
10/27/2011US20110263575 Compounds Useful as Protein Kinase Inhibitors
10/27/2011US20110263574 Pirenzepine as otoprotective agent
10/27/2011US20110263573 Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
10/27/2011US20110263572 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5-receptor antagonists
10/27/2011US20110263571 Novel amide derivative and use thereof as medicine
10/27/2011US20110263570 Pyrimidine derivatives as gpcr modulators for use in the treatment of obesity and diabetes
10/27/2011US20110263569 Ryanodine channel binders and uses thereof
10/27/2011US20110263568 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
10/27/2011US20110263567 Compounds for inhibiting semicarbazide-sensitive amine oxidase (ssao) / vascular adhesion protein-1 (vap-1) and uses thereof for treatment and prevention of diseases
10/27/2011US20110263566 7-Hydroxy-benzoimidazole-4-yl-methanone Derivatives and PBK Inhibitors Containing the Same
10/27/2011US20110263565 Compounds
10/27/2011US20110263564 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
10/27/2011US20110263563 Ansamycin Hydroquinone Compositions
10/27/2011US20110263562 Bicyclic compound
10/27/2011US20110263561 Novel pyrrolidone derivatives for use as MetAP-2 inhibitors
10/27/2011US20110263560 Organic Compounds
10/27/2011US20110263559 Indazole compounds useful as ketohexokinase inhibitors
10/27/2011US20110263558 Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases
10/27/2011US20110263557 Compounds and compositions as modulators of gpr119 activity
10/27/2011US20110263556 New Compounds
10/27/2011US20110263555 TGR5 Modulators and Methods of Use Thereof
10/27/2011US20110263554 Screen for inhibitors of filovirus and uses therefor
10/27/2011US20110263553 Steroid analogues for neuroprotection
10/27/2011US20110263552 Modulation of side effect profile of 5-alpha reductase inhibitor therapy
10/27/2011US20110263551 Method for treating otitis externa
10/27/2011US20110263550 Therapeutic agent for chronic obstructive pulmonary disease
10/27/2011US20110263549 4-dimethylamino-phenyl-substituted naphthyridines, and use thereof as medicaments
10/27/2011US20110263548 Pyridone and pyridazone analogues as gpr119 modulators
10/27/2011US20110263547 C-19 steroids for specific therapeutic uses
10/27/2011US20110263546 Polyhydroxylated Bile Acids for Treatment of Biliary Disorders
10/27/2011US20110263545 Hepatoprotectant acetaminophen mutual prodrugs
10/27/2011US20110263544 1-Phenylpyrrole Derivatives
10/27/2011US20110263543 Anti inflammatory compounds
10/27/2011US20110263542 Methods to treat pain using an alpha-2 adrenergic agonist and an endothelin antagonist
10/27/2011US20110263541 Kinase inhibitors and their use as pharmaceutical agents
1 ... 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 ... 7860